After finishing at $5.12 in the prior trading day, Vincerx Pharma Inc (NASDAQ: VINC) closed at $6.06, up 18.36%. In other words, the price has increased by $+0.94 from its previous closing price. On the day, 707956 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
Our goal is to gain a better understanding of VINC by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.58 and its Current Ratio is at 2.58. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on January 14, 2022, initiated with a Buy rating and assigned the stock a target price of $25.
On December 23, 2021, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $25.
On November 01, 2021, SVB Leerink started tracking the stock assigning a Outperform rating and target price of $24.SVB Leerink initiated its Outperform rating on November 01, 2021, with a $24 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 11 ’23 when Seelenberger Alexander A. bought 10,500 shares for $0.95 per share. The transaction valued at 9,968 led to the insider holds 30,280 shares of the business.
Hamdy Ahmed MD bought 5,400 shares of VINC for $5,167 on Aug 10 ’23. The insider now owns 96,060 shares after completing the transaction at $0.96 per share. On Aug 10 ’23, another insider, THOMAS TOM C, who serves as the insider of the company, bought 5,000 shares for $0.95 each. As a result, the insider paid 4,750 and bolstered with 219,935 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VINC now has a Market Capitalization of 129.57M and an Enterprise Value of 111.53M.
Stock Price History:
Over the past 52 weeks, VINC has reached a high of $9.37, while it has fallen to a 52-week low of $0.61. The 50-Day Moving Average of the stock is 3.49, while the 200-Day Moving Average is calculated to be 1.61.
Shares Statistics:
The stock has traded on average 1.07M shares per day over the past 3-months and 548.11k shares per day over the last 10 days, according to various share statistics. A total of 21.24M shares are outstanding, with a floating share count of 13.45M. Insiders hold about 37.11% of the company’s shares, while institutions hold 45.87% stake in the company. Shares short for VINC as of Feb 29, 2024 were 442.4k with a Short Ratio of 0.81, compared to 344.18k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.07% and a Short% of Float of 2.85%.
Earnings Estimates
Its stock is currently analyzed by 3 different market analysts. On average, analysts expect EPS of -$0.37 for the current quarter, with a high estimate of -$0.24 and a low estimate of -$0.44, while EPS last year was -$0.65. The consensus estimate for the next quarter is -$0.29, with high estimates of -$0.19 and low estimates of -$0.4.
Analysts are recommending an EPS of between -$1.9 and -$2.14 for the fiscal current year, implying an average EPS of -$2.04. EPS for the following year is -$0.85, with 2 analysts recommending between -$0.66 and -$1.04.
